In an effort to identify determinants of resistance to endocrine therapy for breast cancer, a siRNA screen against the whole human kinome revealed CDK10 as a target whose silencing allowed cultured MCF7 breast cancer cells to grow efficiently in the presence of tamoxifen. This evidence concerns the gene CDK10 and breast carcinoma.